Dr Chari on the FDA Approval of Talquetamab in Relapsed/Refractory Multiple Myeloma

Press/Media

Period	14 Aug 2023

Media coverage

Title	Dr Chari on the FDA Approval of Talquetamab in Relapsed/Refractory Multiple Myeloma
Media name/outlet	OncLive
Country/Territory	United States
Date	14/08/23
URL	ct.moreover.com/?a=51548077464&p=1gw&v=1&x=gSrFLmf0RQ90iVG-XxdN3g
Persons	Ajai Chari